Essayer OR - Gratuit
Cipla: USFDA approval clears path for Abraxane launch
Financial Express Chandigarh
|April 15, 2025
CIPLA ANNOUNCED ON April 11 that it has received final approval from the USFDA for its Abraxane (Paclitaxel protein-bound particles for injectable suspension [albumin bound], 100 mg/vial, single-dose vial) ANDA.
-
The approval pertains to Cipla's Goa site, which was cleared by the USFDA in October 2024. While the approval is not entirely unexpected, there were concerns about potential delays due to the possibility of a pre-approval inspection. However, we think the approval thus presents visibility on launch. Cipla expects to launch the product in the first half of FY26, earlier than its initial guidance of a second-half FY26 launch. However, as production ramp-up and supply initiation may take time, we anticipate the launch to occur towards the end of 1HFY26.
Cette histoire est tirée de l'édition April 15, 2025 de Financial Express Chandigarh.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Financial Express Chandigarh
Financial Express Chandigarh
Gold, silver rally to extend record run, say analysts
GOLD AND SILVER prices are poised to maintain their record-setting rally in the coming week as investors focus on global inflation data and key macroeconomic indicators that shape central bank policy paths, analysts said.
1 min
December 15, 2025
Financial Express Chandigarh
ED aims to end legacy FERA cases by early 2026
THE ENFORCEMENT DIRECTORATE has decided to bring to a conclusion cases registered under the Foreign Exchange Regulation Act (FERA), which was repealed by the country more than 25 years ago in 1998.
1 min
December 15, 2025
Financial Express Chandigarh
Sebi fines Refex for insider trading
Industries on Sunday said the Securities and Exchange Board of India (Sebi) has imposed a penalty of ₹10 lakh on its chairman and managing director Anil Jain, and a joint penalty of ₹25 lakh on Kamlesh Jain and the Jain Family Trust, for alleged insider trading violations involving the company’s shares.
1 min
December 15, 2025
Financial Express Chandigarh
Major customs rejig on the anvil
THE GOVERNMENT MAY undertake a major exercise to reduce the basic customs duty or import tariff on a large number of goods, especially critical raw materials and intermediate goods, in the Budget for FY27.
1 min
December 15, 2025
Financial Express Chandigarh
Delhi AQI at 461 sets record for 2nd-worst Dec day
THE AQI IN Delhi climbed to 461 on Sunday and marked the city’s most polluted day this winter and the second-worst December air quality day on record, as weak winds and low temperatures trapped pollutants close to the surface.
2 mins
December 15, 2025
Financial Express Chandigarh
Fintechs eye gains from cross-border payments
Easier RBI norms end dependence on banks, open up the market
2 mins
December 15, 2025
Financial Express Chandigarh
Budget may unveil next round of PSB reforms
FDI hike, phased dilution of govt’s stake to 51% on the table
1 min
December 15, 2025
Financial Express Chandigarh
Nifty still fumbling at the top
THE NIFTY CLOSED Friday with a gain of 148 points or 0.57%, ending the week at 26,046, but still recording a weekly loss of 140 points or 0.53%.
2 mins
December 15, 2025
Financial Express Chandigarh
‘Consumption demand likely to be sustained’
CS SETTY, CHAIRMAN, SBI
1 mins
December 15, 2025
Financial Express Chandigarh
When Prada prices our heritage
IT REVEALS GLOBAL APPETITE FOR INDIAN DESIGNS—AND INDIA'S FAILURE TO MONETISE THEM
3 mins
December 15, 2025
Listen
Translate
Change font size